Endogenous non-enzymatic antioxidants in the human body

Advances in Medical Sciences

Volumn 63, Issue 1, 2018, Pages 68-78

  Mirończuk Chodakowska, Iwona ^a   Witkowska, Anna Maria ^a   Zujko, Małgorzata Elżbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Antioxidants; Endogenous; Human; Non enzymatic

Indexed keywords

ALBUMIN; ANTIOXIDANT; BILIRUBIN; CERULOPLASMIN; FERRITIN; GLUTATHIONE; LACTOFERRIN; MELATONIN; METAL BINDING PROTEIN; METALLOTHIONEIN; POLYAMINE; PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSFERRIN; UBIDECARENONE; UNCLASSIFIED DRUG; URIC ACID;

ARTICLE; BODY COMPOSITION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; INNATE IMMUNITY; METAL BINDING; OXIDATIVE STRESS; PHYSIOLOGICAL PROCESS; PROTEIN FUNCTION; BIOLOGICAL MODEL; METABOLISM;

ANTIOXIDANTS; HUMAN BODY; HUMANS; MODELS, BIOLOGICAL; PROTEINS;

EID: 85027414097     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2017.05.005     Document Type: Review

References (166)

1. Weidinger, A., Kozlov, A.V., Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction. Biomolecules 5:2 (2015), 472–484.
2. Lü, J.M., Lin, P.H., Yao, Q., Chen, Ch.., Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med 14:4 (2010), 840–860.
3. Csányi, G., Miller, F.J. Jr., Oxidative stress in cardiovascular disease. Int J Mol Sci 15 (2014), 6002–6008.
4. Zujko, M.E., Witkowska, A.M., Górska, M., Wilk, J., Krętowski, A., Reduced intake of dietary antioxidants can impair antioxidant status in type 2 diabetes patients. Pol Arch Med Wewn 124:11 (2014), 599–607.
5. Gęgotek, A., Nikliński, J., Žarković, N., Žarković, K., Waeg, G., Łuczaj, W., et al. Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells. Redox Biol 9 (2016), 210–219.
6. Ghavipour, M., Sotoudeh, G., Tavakoli, E., Mowla, K., Hasanzadeh, J., Mazloom, Z., Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in rheumatoid arthritis patients. Eur J Clin Nutr 71:1 (2016), 92–96, 10.1038/ejcn.2016.151.
7. Łuszczewski, A., Matyska-Piekarska, E., Trefler, J., Wawer, I., Łącki, J., Śliwińska-Stańczyk, P., Reactive oxygen species −physiological and pathological function in the human body. Reumatolog 45:5 (2007), 284–289.
8. Rosen, H., Klebanoff, S.J., Wang, Y., Brot, N., Heinecke, J.W., Fu, X., Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils. Proc Natl Acad Sci 106:44 (2009), 18686–18691.
9. Schwab, L., Goroncy, L., Palaniyandi, S., Gautam, S., Triantafyllopoulou, A., Mocsai, A., et al. Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage. Nat Med 20:6 (2014), 648–654.
10. Birben, E., Sahiner, U.M., Sackesen, C., Erzurum, S., Kalayci, O., Oxidative stress and antioxidant defense. World Allergy Organ J 5:1 (2012), 9–19.
11. Lazo-de-la-Vega-Monroy, M.L., Fernández-Mejía, C., Oxidative stress in diabetes mellitus and the role of vitamins with antioxidant action [chapter 9]. Morales-González, J.A., (eds.) Oxidative stress and chronic degenerative diseases – a role for antioxidants, 2013, In-Tech, Rijeka, Croatia.
12. Wu, J.Q., Kosten, T.R., Zhang, X.Y., Free radicals, antioxidant defense systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 46 (2013), 200–206.
13. Babula, P., Masarik, M., Adam, V., Eckschlager, T., Stiborova, M., Trnkova, L., et al. Mammalian metallothioneins: properties and functions. Metallomics 4:8 (2012), 739–750.
14. Muftuoglu, M., Mori, M.P., de Souza-Pinto, N.C., Formation and repair of oxidative damage in the mitochondrial DNA. Mitochondrion 17 (2014), 164–181.
15. Zujko, M.E., Witkowska, A.M., Waśkiewicz, A., Sygnowska, E., Estimation of dietary intake and patterns of polyphenol consumption in Polish adult population. Adv Med Sci 57:2 (2012), 375–384.
16. Zujko, M.E., Witkowska, A.M., Waśkiewicz, A., Mirończuk-Chodakowska, I., Dietary antioxidant and flavonoid intakes are reduced in the elderly. Oxid Med Cell Longev, 2015, 2015, 843173.
17. Zujko, M.E., Witkowska, A.M., Waśkiewicz, A., Piotrowski, W., Terlikowska, K.M., Dietary antioxidant capacity of the patients with cardiovascular disease in a cross-sectional study. Nutr J 14:26 (2015), 1–13.
18. Taverna, M., Marie, A.L., Mira, J.P., Guidet, B., Specific antioxidant properties of human serum albumin. Ann Intensive Care, 3(1), 2013, 4.
19. Faisal, A.A., Al-Salih, R.M.H., Assi, A.N., Study of effect of thyroidectomy on serum oxidant antioxidants status. Int J Curr Microbiol App Sci 4:4 (2015), 1051–1060.
20. Hineno, A., Kaneko, K., Yoshida, K., Ikeda, S., Ceruloplasmin protects against rotenone- induced oxidative stress and neurotoxicity. Neurochem Res 36:11 (2011), 2127–2135.
21. Vincent, J.L., Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol 23:2 (2009), 183–191.
22. Plantier, J.L., Duretz, V., Devos, V., Urbain, R., Jorieux, S., Comparison of antioxidant properties of different therapeutic albumin preparations. Biologicals 44:4 (2016), 226–233.
23. Kreutzer, U., Jue, T., Role of myoglobin as a scavenger of cellular NO in myocardium. Am J Physiol Heart Circ Physiol 286:3 (2004), 985–991.
24. Irato, P., Santovito, G., Piccinni, E., Albergoni, V., Oxidative burst and metallothionein as a scavenger in macrophages. Immunol Cell Biol 79:3 (2001), 251–254.
25. Milto, I.V., Suhodolo, I.V., Prokopieva, V.D., Klimenteva, T.K., Molecular and cellular bases of iron metabolism in humans. Biochemistry (Mosc) 81:6 (2016), 549–564.
26. Fang, F.C., Antimicrobial actions of reactive oxygen species. MBio 2:5 (2011), e00141–11.
27. Jomova, K., Valko, M., Advances in metal-induced oxidative stress and human disease. Toxicology 283:2–3 (2011), 65–87.
28. You, L.H., Li, Z., Duan, X.L., Zhao, B.L., Chang, Y.Z., Shi, Z.H., Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress. Brain Res 1642 (2016), 33–42.
29. Peters, D.G., Connor, J.R., Meadowcroft, M.D., The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: two sides of the same coin. Neurobiol Dis 81 (2015), 49–65.
30. Anderson, C.P., Shen, M., Eisenstein, R.S., Leibold, E.A., Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta 1823:9 (2012), 1468–1483.
31. Chauhan, A., Chauhan, V., Brown, W.T., Cohen, I., Oxidative stress in autism: increased lipid peroxidation andreduced serum levels of ceruloplasmin and transferrin − the antioxidant proteins. Life Sci 75 (2004), 2539–2549.
32. Talebi, R., Ahmadi, A., Afraz, F., Abdoli, R., Parkinson's disease and lactoferrin: analysis of dependent protein networks. Gene Reports 4 (2016), 177–183.
33. Zhang, J., Zhang, H., Wang, L., Guo, X., Wang, X., You, H., Antioxidant activities of the rice endosperm protein hydrolysate: identification of the active peptide. Eur Food Res Technol 229:4 (2009), 709–719.
34. Manso, M.A., Miguel, M., Even, J., Hernández, R., Aleixandre, A., López-Fandiño, R., Effect of the long-term intake of an egg white hydrolysate on the oxidative status and blood lipid profile of spontaneously hypertensive rats. Food Chem 109:2 (2008), 361–367.
35. Nimalaratne, C., Wu, J., Hen egg as an antioxidant food commodity: a review. Nutrients 7:10 (2015), 8274–8293.
36. Garcés-Rimón, M., González, C., Uranga, J.A., López-Miranda, V., López-Fandiño, R., Miguel, M., Pepsin egg white hydrolysate ameliorates obesity-related oxidative stress, inflammation and steatosis in zucker fatty rats. PLoS One, 11(3), 2016, e0151193.
37. Eid, C., Hémadi, M., Ha-Duong, N.T., El Hage Chahine JM: Iron uptake and transfer from ceruloplasmin to transferrin. Biochim Biophys Acta 1840:6 (2014), 1771–1781.
38. Klimczak, A., Kubiak, K., Cybulska, M., Kula, A., Ł, Dziki, Malinowska, K., Etiology of colorectal cancer and antioxidant barrier of the organism. Pol Merkur Lek 28:165 (2010), 223–226 [In Polish].
39. Levy, R., Sobolev, V., Edelman, M., First- and second-shell metal binding residues in human proteins are disproportionately associated with disease-related SNPs. Hum Mutat 32:11 (2011), 1309–1318.
40. Salvayre, R., Negre-Salvayre, A., Camaré, C., Oxidative theory of atherosclerosis and antioxidants. Biochimie 125 (2016), 281–296.
41. Kibel, A., Belovari, T., Drenjancevic-Peric, I., The role of transferrin in atherosclerosis. Med Hypotheses 70 (2008), 793–797.
42. Lakkappa, N., Krishnamurthy, P.T., Hammock, B.D., Velmurugan, D., Bharath, M.M., Possible role of epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders. Med Hypotheses 93 (2016), 161–165.
43. Hadzhieva, M., Kirches, E., Mawrin, C., Review: iron metabolism and the role of iron in neurodegenerative disorders. Neuropathol Appl Neurobiol 40:3 (2014), 240–257.
44. Weinreb, O., Mandel, S., Youdim, M.B., Amit, T., Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators. Free Radic Biol Med 62 (2013), 52–64.
45. Tramutola, A., Lanzillotta, C., Perluigi, M., Butterfield, D.A., Oxidative stress, protein modification and Alzheimer disease. Brain Res Bull, 2016 pS0361-9230(16)30129-0.
46. Kałużna-Czaplińska, J., Jóźwik-Pruska, J., Chromatographic and mass spectrometric techniques in studies on oxidative stress in autism. J Chromatogr B Analyt Technol Biomed Life Sci 1019 (2016), 4–14.
47. Pecorelli, A., Leoncini, S., De Felice, C., Signorini, C., Cerrone, C., Valacchi, G., et al. Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism. Brain Dev 35:2 (2013), 146–154.
48. Garlet, T.R., Parisotto, E.B., de Medeiros Gda, S., Pereira, L.C., Moreira, E.A., Dalmarco, E.M., et al. Systemic oxidative stress in children and teenagers with Down syndrome. Life Sci 93:16 (2013), 558–563.
49. Parisotto, E.B., Garlet, T.R., Cavalli, V.L., Zamoner, A., da Rosa, J.S., Bastos, J., et al. Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome. Res Dev Disabil 35:6 (2014), 1228–1236.
50. Malakooti, N., Pritchard, M.A., Adlard, P.A., Finkelstein, D.I., Role of metal ions in the cognitive decline of Down syndrome. Front Aging Neurosci, 6, 2014, 136.
51. Bošković, M., Vovk, T., Kores Plesničar, B., Grabnar, I., Oxidative stress in schizophrenia. Curr Neuropharmacol 9:2 (2011), 301–312.
52. Han, Y., Xi, Q.Q., Dai, W., Yang, S.H., Gao, L., Su, Y.Y., et al. Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders. Int J Dev Neurosci 46 (2015), 27–32.
53. Sertan Copoglu, U., Virit, O., Hanifi Kokacya, M., Orkmez, M., Bulbul, F., Binnur Erbagci, A., et al. Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients. Psychiatry Res 229:1–2 (2015), 200–205.
54. Theil, E.C., Coordinating responses to iron and oxygen stress with DNA and mRNA promoters: the Ferritin story. Biometals 20:3–4 (2007), 513–521.
55. Arosio, P., Ingrassia, R., Cavadini, P., A family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790:7 (2009), 589–599.
56. Theil, E.C., Ferritin The protein nanocage and iron biomineral in health and in disease. Inorg Chem 52:21 (2013), 12223–12233.
57. Schulpis, K.H., Papastamataki, M., Stamou, H., Papassotiriou, I., Margeli, A., The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children. Acta Paediatr 99:10 (2010), 1565–1570.
58. Liu, Y., Wang, B., Liu, X., Xie, X., Gu, W., Li, H., et al. Clinical variations of serum levels of ferritin, folic acid and vitamin B12 in acute leukemia patients. J Med Colleges Pla 26:5 (2011), 264–270.
59. Iasfisco, M., Di Foggia, M., Bonora, S., Part, M., Roveri, N., Adsorption and spectroscopic characterization of lactoferrin on hydroxyapatite nanocrystals. Dalton Trans 40:4 (2011), 820–827.
60. Yen, C.C., Shen, C.J., Hsu, W.H., Chang, Y.H., Lin, H.T., Chen, C.M., et al. Lactoferrin: an iron-binding protein against Escherichia coli infection. Biometals 24:4 (2011), 585–594.
61. Burrow, H., Kanwar, R.K., Mahidhara, G., Kanwar, J.R., Effect of selenium-saturated bovine lactoferrin (Se-bLF) on antioxidant enzyme activities in human gut epithelial cells under oxidative stress. Anticancer Agents Med Chem 11:8 (2011), 762–771.
62. Gibbons, J.A., Kanwar, R.K., Kanwar, J.R., Lactoferrin and cancer in different cancer models. Front Biosci (Schol Ed) 3 (2011), 1080–1088.
63. Pecorini, C., Sassera, D., Rebucci, R., Saccone, F., Bandi, C., Baldi, A., Evaluation of the protective effect of bovine lactoferrin against lipopolysaccharides in a bovine mammary epithelial cell line. Vet Res Commun 34:3 (2010), 267–276.
64. Artym, J., The role of lactoferrin in the iron metabolism. Part II. Antimicrobial and anti-inflammatory effect of lactoferrin by chelation of iron. Postepy Hig Med Dosw 64 (2010), 604–616 [Article in Polish].
65. Fernández-Real, J.M., García-Fuentes, E., Moreno-Navarrete, J.M., Murri-Pierri, M., Garrido-Sánchez, L., Ricart, W., et al. Fat overload induces changes in circulating lactoferrin that are associated with postprandial lipemia and oxidative stress in severely obese subjects. Obesity (Silver Spring) 18:3 (2010), 482–488.
66. Wang, B., Molecular determinants of milk lactoferrin as a bioactive compound in early neurodevelopment and cognition. J Pediatr 173:Suppl (2016), S29–36.
67. Kruzel, M.L., Actor, J.K., Boldogh, I., Zimecki, M., Lactoferrin in health and disease. Postepy Hig Med Dosw 61 (2007), 261–267.
68. Roche, M., Rondeau, P., Singh, N.R., Tarnus, E., Bourdon, E., The antioxidant properties of serum albumin. FEBS Lett 582:13 (2008), 1783–1787.
69. Rondeau, P., Bourdon, E., The glycation of albumin: structural and functional impacts. Biochimie 93:4 (2011), 645–658.
70. Lapenna, D., Ciofani, G., Ucchino, S., Pierdomenico, S.D., Cuccurullo, C., Giamberardino, M.A., et al. Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques. Clin Biochem 43:18 (2010), 1458–1460.
71. Jin, S.M., Hong, Y.J., Jee, J.H., Bae, J.C., Hur, K.Y., Lee, M.K., et al. Change in serum albumin concentration is inversely and independently associated with risk of incident metabolic syndrome. Metabolism 65:11 (2016), 1629–1635.
72. Ikezaki, H., Furusyo, N., Ihara, T., Hayashi, T., Ura, K., Hiramine, S., et al. Glycated albumin as a diagnostic tool for diabetes in a general Japanese population. Metabolism 64:6 (2015), 698–705.
73. Alvarez-Perez, F.J., Castelo-Branco, M., Alvarez-Sabin, J., Albumin level and stroke: potential association between lower albumin level and cardioembolic aetiology. Int J Neurosci 121:1 (2011), 25–32.
74. Paradis, M., Gagné, J., Mateescu, M.A., Paquin, J., The effects of nitric oxide-oxidase and putative gluthatione?peroxidase activities of ceruloplasmin on the viability of cardiomycetes exposed to hydrogen peroxide. Free Radic Biol Med 49:12 (2010), 2019–2027.
75. Bozkus, F., Ulas, T., San, I., Yesilova, Y., Iynen, I., Guldur, M.E., et al. Evaluation of ceruloplasmin levels in patients undergoing surgical interventions with nasal polyps. Auris Nasus Larynx 40:3 (2013), 282–285.
76. Verma, V.K., Ramesh, V., Tewari, S., Gupta, R.K., Sinha, N., Pandey, C.M., Role of bilirubin, Vitamin C and ceruloplasmin as antioxidant in coronary artery disease [CAD]. Indian J Clin Biochem 20:2 (2005), 68–74.
77. Shin, E.J., Jeong, J.H., Chung, C.K., Kim, D.J., Wie, M.B., Park, E.S., et al. Ceruloplasmin is an endogenous protectant against kainate neurotoxicity. Free Radic Biol Med 84 (2015), 355–372.
78. Zhao, N., Jin, L., Fei, G., Zheng, Z., Zhong, C., Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease. Parkinsonism Relat Disord 20:11 (2014), 1177–1180.
79. Schrag, M., Mueller, C., Zabel, M., Crofton, A., Kirsch, W.M., Ghribi, O., et al. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis 59 (2013), 100–110.
80. Wright, T.J., Davis, R.W., Myoglobin extraction from mammalian skeletal muscle and oxygen affinity determination under physiological conditions. Protein Expr Purif 107 (2015), 50–55.
81. Mandal, P., Bardhan, M., Ganguly, T., Spectroscopic investigations to reveal the nature of interactions between the haem protein myoglobin and the dye rhodamine 6G. Luminescence 27:4 (2012), 285–291.
82. Hendgen-Cotta, U.B., Flögel, U., Kelm, M., Rassaf, T., Unmasking the Janus face of myoglobin in health and disease. J Exp Biol 213:Pt 16 (2010), 2734–2740.
83. Flögel, U., Fago, A., Rassaf, T., Keeping the heart in balance: the functional interactions of myoglobin with nitrogen oxides. J Exp Biol 213:Pt 16 (2010), 2726–2733.
84. Hendgen-Cotta, U.B., Kelm, M., Rassaf, T., Myoglobin functions in the heart. Free Radic Biol Med 73 (2014), 252–259.
85. Hendgen-Cotta, U.B., Kelm, M., Rassaf, T., A highlight of myoglobin diversity: the nitrite reductase activity during myocardial ischemia-reperfusion. Nitric Oxide 22:2 (2010), 75–82.
86. Kang, Y.J., Metallothionein redox cycle and function. Exp Biol Med 231 (2006), 1459–1467.
87. Adams, S.V., Barrick, B., Christopher, E.P., Shafer, M.M., Makar, K.W., Song, X., et al. Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc. Toxicol Appl Pharmacol 289:3 (2015), 381–388.
88. Maret, W., Krezel, A., Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 13:7–8 (2007), 371–375.
89. Giles, N.M., Watts, A.B., Giles, G.I., Fry, F.H., Littlechild, J.A., Jacob, C., Metal and redox modulation of cysteine protein function. Chem Biol 10:August (8) (2003), 677–693.
90. Braga, M.M., Dick, T., de Oliveira, D.L., Scopel-Guerra, A., Mussulini, B.H.M., Souza, D.O., et al. Evaluation of zinc effect on cadmium action in lipid peroxidation and metallothionein levels in the brain. Toxicol Rep 2 (2015), 858–863.
91. You, H.J., Oh, D.H., Choi, C.Y., Lee, D.G., Hahm, K.S., Moon, A.R., et al. Protective effect of metallothionein-III on DNA damage in response to reactive oxygen species. Biochim Biophys Acta 1573:1 (2002), 33–38.
92. Heger, Z., Rodrigo, M.A., Krizkova, S., Ruttkay-Nedecky, B., Zalewska, M., Del Pozo, E.M., et al. Metallothionein as a scavenger of free radicals − new cardioprotective therapeutic agent or initiator of tumor chemoresistance?. Curr Drug Targets 17:12 (2016), 1438–1451.
93. Adam, P., Křížková, S., Heger, Z., Babula, P., Pekařík, V., Vaculovičoá, M., et al. Metallothioneins in prion- and amyloid-Related diseases. J Alzheimers Dis 51:3 (2016), 637–656.
94. Nielson, K.B., Atkin, C.L., Winge, D.R., Distinct metal-binding configurations in metallothionein. J Biol Chem 260:9 (1985), 5342–5350.
95. Waeytens, A., De Vos, M., Laukens, D., Evidence for a potential role of metallothioneins in inflammatory bowel diseases. Mediators Inflamm, 2009, 2009, 729172, 10.1155/2009/729172.
96. Gomulkiewicz, A., Jablonska, K., Pula, B., Grzegrzolka, J., Borska, S., Podhorska-Okolow, M., et al. Expression of metallothionein 3 in ductal breast cancer. Int J Oncol 49:6 (2016), 2487–2497.
97. Petrova, E.V., Korotkova, E.I., Kratochvil, B., Voronova, O.A., Dorozhko, E.V., Bulycheva, E.V., Investigation of coenzyme q 10 by voltammetry. Procedia Chem 10 (2014), 173–178.
98. Jankowski, J., Korzeniowska, K., Cieślewicz, A., Jabłecka, A., Coenzyme Q10 – A new player in the treatment of heart failure?. Pharmacol Rep 68:5 (2016), 1015–1019.
99. Bentinger, M., Tekle, M., Dallner Coenzyme, G.Q., ?biosynthesis and functions. Biochem Biophys Res Commun 396:1 (2010), 74–79.
100. Acosta, J.M., Vazquez Fonseca, L., Desbats, M.A., Cerqua, C., Zordan, R., Trevisson, E., et al. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta 8 (2016), 1079–1085.
101. Navasa, P., Villalba, J.M., de Cabo, R., The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion 7 (2007), 34–40.
102. Noh, Y.H., Kim, K.Y., Shim, M.S., Choi, S.H., Choi, S., Ellisman, M.H., et al. Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes. Cell Death Dis, 4, 2013, e820.
103. Donnino, M.W., Cocchi, M.N., Salciccioli, J.D., Kim, D., Naini, A.B., Buettner, C., et al. Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock. Crit Care, 15(4), 2011, R189.
104. Cooney, R.V., Dai, Q., Gao, Y.T., Chow, W.H., Franke, A.A., Shu, X.O., et al. Low plasma coenzyme Q(10) levels and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 20:6 (2011), 1124–1130.
105. Blatt, T., Littarru, G.P., Biochemical rationale and experimental data on the antiaging properties of CoQ(10) at skin level. Biofactors 37:5 (2011), 381–385.
106. Lee, B.J., Huang, Y.C., Chen, S.J., Lin, P.T., Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition 28:3 (2012), 250–255.
107. Ercan, P., El, S.N., Changes in content of coenzyme Q10 in beef muscle, beef liver and beef heart with cooking and in vitro digestion. J Food Comp Anal 24:8 (2011), 1136–1140.
108. Forman, H.J., Zhang, H., Rinna, A., Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 30:1-2 (2009), 1–12.
109. Lu, S.C., Glutathione synthesis. Biochim Biophys Acta 1830:5 (2013), 3143–3153.
110. Kosower, N.S., Kosower, E.M., The glutathione status of cells. Int Rev Cytol 54 (1978), 109–160.
111. Samuelsson, M., Vainikka, L., Öllinger K: Glutathione in the blood and cerebrospinal fluid: a study in healthy male volunteers. Neuropeptides 45:4 (2011), 287–292.
112. Marí, M., Morales, A., Colell, A., García-Ruiz, C., Fernández-Checa, J.C., Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11:11 (2009), 2685–2700.
113. Meister, A., Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 269:13 (1994), 9397–9400.
114. Yang, Y.T., Whiteman, M., Gieseg, S.P., Intracellular glutathione protects human monocyte-derived macrophages from hypochlorite damage. Life Sci 90:17–18 (2012), 682–688.
115. Lushchak, V.I., Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids, 2012, 2012, 736837.
116. Rahman, K., Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:2 (2007), 219–236.
117. Alli, J.A., Kehinde, A.O., Kosoko, A.M., Ademowo, O.G., Oxidative stress and reduced vitamins C and E levels are associated with multi-drug resistant tuberculosis. J Tuberc Res 2 (2014), 52–58.
118. Chatterjee, A., Reduced glutathione: a radioprotector or a modulator of DNA-repair activity?. Nutrients 5:2 (2013), 525–542.
119. Lippi, G., Montagnana, M., Franchini, M., Favaloro, E.J., Targher, G., The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 392:1-2 (2008), 1–7.
120. Maiuolo, J., Oppedisano, F., Gratteri, S., Muscoli, C., Mollace, V., Regulation of uric acid metabolism and excretion. Int J Cardiol 213 (2016), 8–14.
121. Ekpenyong, C., Akpan, E., Abnormal serum uric acid levels in health and disease: a double-edged sword. Am J Intern Med 2:6 (2014), 113–130.
122. Sautin, Y.Y., Nakagawa, T., Zharikov, S., Johnson, R.J., Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293:2 (2007), C584–96.
123. Reyes, A.J., The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur J Heart Fail 7:4 (2005), 461–467.
124. Stinefelt, B., Leonard, S.S., Blemings, K.P., Shi, X., Klandorf, H., Free radical scavenging, DNA protection, and inhibition of lipid peroxidation mediated by uric acid. Ann Clin Lab Sci 35:1 (2005), 37–45.
125. Bowman, G.L., Shannon, J., Frei, B., Kaye, J.A., Quinn, J.F., Uric acid as a CNS antioxidant. J Alzheimers Dis 19:4 (2010), 1331–1336.
126. Settle, T., Klandorf, H., The role of uric acid as an antioxidant in neurodegenerative disease pathogenesis. Brain Disord Ther, 3, 2014, 129.
127. Pingitore, A., Lima, G.P., Mastorci, F., Quinones, A., Iervasi, G., Vassalle, C., Exercise and oxidative stress: potential effects of antioxidant dietary strategies in sports. Nutrition 31:7–8 (2015), 916–922.
128. Aloia, E., Sciaccaluga, C., Low acid uric in primary prophylaxis: worthy. Int J Cardiol 215 (2016), 223–226.
129. Annanmaki, T., Pohja, M., Parviainen, T., Hakkinen, P., Murros, K., Uric acid and cognition in Parkinson's disease: a follow-up study. Parkinsonism Relat Disord 17:5 (2011), 333–337.
130. Clémençon, B., Lüscher, B.P., Fine, M., Baumann, M.U., Surbek, D.V., Bonny, O., et al. Expression, purification, and structural insights for the human uric acid transporter, GLUT9, using the Xenopus laevis oocytes system. PLoS One, 9(10), 2014, e108852.
131. Okazaki, H., Shirakabe, A., Kobayashi, N., Hata, N., Shinada, T., Matsushita, M., et al. The prognostic impact of uric acid in patients with severely decompensated acute heart failure. J Cardiol, 2016 S0914-5087(16)30074-0.
132. Xia, X., Zhao, C., Peng, F.F., Luo, Q.M., Zhou, Q., Lin, Z.C., et al. Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes. Nutr Metab Cardiovasc Dis 26:1 (2016), 20–26.
133. Kanellis, J., Watanabe, S., Li, J.H., Kang, D.H., Li, P., Nakagawa, T., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:6 (2003), 1287–1293.
134. Hare, J.M., Johnson, R.J., Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 107:15 (2003), 1951–1953.
135. Zurlo, A., Veronese, N., Giantin, V., Maselli, M., Zambon, S., Maggi, S., et al. High serum uric acid levels increase the risk of metabolic syndrome in elderly women: the PRO.V.A study. Nutr Metab Cardiovasc Dis 26:1 (2016), 27–35.
136. Dhaun, N., Vachiery, J.L., Benza, R.L., Naeije, R., Hwang, L.J., Liu, X., et al. Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associations. J Heart Lung Transplant 33:5 (2014), 521–527.
137. Hwu, C.M., Lin, K.H., Uric acid and the development of hypertension. Med Sci Monit 16:10 (2010), RA224–30.
138. See, L.C., Kuo, C.F., Chuang, F.H., Li, H.Y., Chen, Y.M., Chen, H.W., et al. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. J Rheumatol 36:8 (2009), 1691–1698.
139. Mazzali, M., Kanbay, M., Segal, M.S., Shafiu, M., Jalal, D., Feig, D.I., et al. Uric acid and hypertension: cause or effect?. Curr Rheumatol Rep 12:2 (2010), 108–117.
140. Waring, W.S., Adwani, S.H., Breukels, O., Webb, D.J., Maxwell, S.R.J., Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 90:2 (2004), 155–159.
141. Hsu, S.P., Pai, M.F., Peng, Y.S., Chiang, C.K., Ho, T.I., Hung, K.Y., Serum uric acid levels show a ‘J-shaped’ association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 19 (2004), 457–462.
142. Schretlen, D.J., Inscore, A.B., Jinnah, H.A., Rao, V., Gordon, B., Pearlson, G.D., Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 21:1 (2007), 136–140.
143. Laudon, M., Frydman-Marom, A., Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders. Int J Mol Sci 15 (2014), 15924–15950.
144. Quera Salva, M.A., Hartley, S., Barbot, F., Alvarez, J.C., Lofaso, F., Guilleminault, C., Circadian rhythms, melatonin and depression. Curr Pharm Des 17:15 (2011), 1459–1470.
145. Ozdinc, S., Oz, G., Ozdemir, C., Kilic, I., Karakaya, Z., Bal, A., et al. Melatonin: is it an effective antioxidant for pulmonary contusion?. J Surg Res 204:2 (2016), 445–451.
146. Hardeland, R., Cardinali, D.P., Srinivasan, V., Spence, D.W., Brown, G.M., Pandi-Perumal, S.R., Melatonin −a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 93:3 (2011), 350–384.
147. Miller, E., Mrowicka, M., Malinowska, K., Saluk-Juszczak, J., Kedziora, J., Effects of whole body cryotherapy on oxidative stress in multiple sclerosis patients. J Therm Biol 35:8 (2010), 406–410.
148. Othman, A.I., El-Missiry, M.A., Amer, M.A., Arafa, M., Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats. Life Sci 83:15–16 (2008), 563–568.
149. Bonnefont-Rousselot, D., Melatonin, Collin F., Action as an antioxidant and potential applications in human disease and aging. Toxicology 278:1 (2010), 55–67.
150. Devore, E.E., Harrison, S.L., Stone, K.L., Holton, K.F., Barrett-Connor, E., Ancoli-Israel, S., et al. Association of urinary melatonin levels and aging-related outcomes in older men. Sleep Med 23 (2016), 73–80.
151. Waseem, M., Tabassum, H., Parvez, S., Neuroprotective effects of melatonin as evidenced by abrogation of oxaliplatin induced behavioral alterations, mitochondrial dysfunction and neurotoxicity in rat brain. Mitochondrion 30 (2016), 168–176.
152. Wang, J., Wang, Z.M., Li, X.M., Li, F., Wu, J.J., Kong, L.Y., et al. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin. Bioorg Med Chem 24:18 (2016), 4324–4338.
153. Navarro-Alarcon, M., Ruiz-Ojeda, F.J., Blanca-Herrera, R.M., Agil, A., Antioxidant activity of melatonin in diabetes in relation to the regulation and levels of plasma Cu, Zn, Fe, Mn, and Se in Zucker diabetic fatty rats. Nutrition 29:5 (2013), 785–789.
154. Bhutani, V.K., Wong, R.J., Stevenson, D.K., Hyperbilirubinemia in preterm neonates. Clin Perinatol 43:2 (2016), 215–232.
155. Zhou, Z.X., Chen, J.K., Hong, Y.Y., Zhou, R., Zhou, D.M., Sun, L.Y., et al. Relationship between the serum total bilirubin and inflammation in patients with psoriasis vulgaris. J Clin Lab Anal 30:5 (2016), 768–775, 10.1002/jcla.21936.
156. Kawamoto, R., Ninomiya, D., Hasegawa, Y., Kasai, Y., Kusunoki, T., Ohtsuka, N., et al. Mildly elevated serum total bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons with type 2 diabetes. Clin Exp Hypertens 38:1 (2016), 107–112.
157. Novotny, L., Vitek, L., Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 228 (2003), 568–571.
158. Stec, D.E., John, K., Trabbic, C.J., Luniwal, A., Hankins, M.W., Baum, J., et al. Bilirubin inding to PPARα inhibits lipid accumulation. PLoS One, 11(4), 2016, e0153427.
159. Zelenka, J., Dvořák, A., Alán, L., Zadinová, M., Haluzík, M., Vítek, L., Hyperbilirubinemia protects against aging-associated inflammation and metabolic deterioration. Oxid Med Cell Longev, 2016, 2016, 6190609.
160. Ziberna, L., Martelanc, M., Franko, M., Passamonti, S., Bilirubin is an endogenous antioxidant in human vascular endothelial cells. Sci Rep, 6, 2016, 29240.
161. Hatfield, G.L., Barclay, R.C., Bilirubin as an antioxidant: kinetic studies of the reaction of bilirubin with peroxyl radicals in solution, micelles, and lipid bilayers. Organic Lett 6:10 (2004), 1539–1542.
162. Abdulhussein, A.A., Wallace, H.M., Polyamines and membrane transporters. Amino Acids 46:3 (2014), 655–660.
163. Minois, N., Carmona-Gutierrez, D., Madeo, F., Polyamines in aging and disease. Aging (Albany NY) 3:8 (2011), 716–732.
164. Tkachenko, A.G., Akhova, A.V., Shumkov, M.S., Nesterova, L.Y., Polyamines reduce oxidative stress in Escherichia coli cells exposed to bactericidal antibiotics. Res Microbiol 163:2 (2012), 83–91.
165. Fujisawa, S., Kadoma, Y., Kinetic evaluation of polyamines as radical scavengers. Anticancer Res 25:2A (2005), 965–969.
166. Rider, J.E., Hacker, A., Mackintosh, C.A., Pegg, A.E., Woster, P.M., Casero, R.V. Jr., Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide. Amino Acids 33:2 (2007), 231–240.